{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:22:44Z","timestamp":1793848964734,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10067-023-06656-y","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T08:02:16Z","timestamp":1685779336000},"page":"2535-2539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cardiovascular issues in rheumatic diseases"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8749-6018","authenticated-orcid":false,"given":"Armen Yuri","family":"Gasparyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,3]]},"reference":[{"issue":"12","key":"6656_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrrheum.2015.112","volume":"11","author":"MT Nurmohamed","year":"2015","unstructured":"Nurmohamed MT, Heslinga M, Kitas GD (2015) Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 11(12):693\u2013704. https:\/\/doi.org\/10.1038\/nrrheum.2015.112","journal-title":"Nat Rev Rheumatol"},{"key":"6656_CR2","doi-asserted-by":"publisher","unstructured":"Shah M, Shinjo SK, Day J, Gupta L (2023) Cardiovascular manifestations in idiopathic inflammatory myopathies. Clin Rheumatol Online ahead of print. https:\/\/doi.org\/10.1007\/s10067-023-06599-4","DOI":"10.1007\/s10067-023-06599-4"},{"key":"6656_CR3","doi-asserted-by":"publisher","unstructured":"Thomas KN, Aggarwal A (2023) Childhood rheumatic diseases: bites not only the joint, but also the heart. Clin Rheumatol Online ahead of print. https:\/\/doi.org\/10.1007\/s10067-023-06621-9","DOI":"10.1007\/s10067-023-06621-9"},{"issue":"3","key":"6656_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/ar4212","volume":"15","author":"J Barsalou","year":"2013","unstructured":"Barsalou J, Bradley TJ, Silverman ED (2013) Cardiovascular risk in pediatric-onset rheumatological diseases. Arthritis Res Ther 15(3):212. https:\/\/doi.org\/10.1186\/ar4212","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"6656_CR5","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s10067-017-3705-7","volume":"37","author":"E Del Giudice","year":"2018","unstructured":"Del Giudice E, Dilillo A, Tromba L et al (2018) Aortic, carotid intima-media thickness and flow-mediated dilation as markers of early atherosclerosis in a cohort of pediatric patients with rheumatic diseases. Clin Rheumatol 37(6):1675\u20131682. https:\/\/doi.org\/10.1007\/s10067-017-3705-7","journal-title":"Clin Rheumatol"},{"issue":"2","key":"6656_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00296-022-05238-6","volume":"43","author":"M Held","year":"2023","unstructured":"Held M, Sestan M, Jelusic M (2023) Obesity as a comorbidity in children and adolescents with autoimmune rheumatic diseases. Rheumatol Int 43(2):209\u2013219. https:\/\/doi.org\/10.1007\/s00296-022-05238-6","journal-title":"Rheumatol Int"},{"key":"6656_CR7","doi-asserted-by":"publisher","unstructured":"Gezer HH, Acer Kasman S, Duru\u00f6z MT (2022) Autonomic dysfunction and cardiovascular risk in psoriatic arthritis. Clin Rheumatol Online ahead of print. https:\/\/doi.org\/10.1007\/s10067-022-06484-6","DOI":"10.1007\/s10067-022-06484-6"},{"issue":"8","key":"6656_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/eurheartj\/ehu403","volume":"36","author":"JC Mason","year":"2015","unstructured":"Mason JC, Libby P (2015) Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J 36(8):482\u201349c. https:\/\/doi.org\/10.1093\/eurheartj\/ehu403","journal-title":"Eur Heart J"},{"issue":"20","key":"6656_CR9","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/heartjnl-2019-316193","volume":"106","author":"E Nikiphorou","year":"2020","unstructured":"Nikiphorou E, de Lusignan S, Mallen CD et al (2020) Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study. Heart 106(20):1566\u20131572. https:\/\/doi.org\/10.1136\/heartjnl-2019-316193","journal-title":"Heart"},{"issue":"2","key":"6656_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/art.38210","volume":"66","author":"I del Rinc\u00f3n","year":"2014","unstructured":"del Rinc\u00f3n I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A (2014) Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol 66(2):264\u2013272. https:\/\/doi.org\/10.1002\/art.38210","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"6656_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jbspin.2016.09.001","volume":"84","author":"J Nicolau","year":"2017","unstructured":"Nicolau J, Lequerr\u00e9 T, Bacquet H, Vittecoq O (2017) Rheumatoid arthritis, insulin resistance, and diabetes. Joint Bone Spine 84(4):411\u2013416. https:\/\/doi.org\/10.1016\/j.jbspin.2016.09.001","journal-title":"Joint Bone Spine"},{"issue":"1","key":"6656_CR12","doi-asserted-by":"publisher","first-page":"e0170108","DOI":"10.1371\/journal.pone.0170108","volume":"12","author":"P Ruscitti","year":"2017","unstructured":"Ruscitti P, Cipriani P, Masedu F et al (2017) Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study. PLoS One 12(1):e0170108. https:\/\/doi.org\/10.1371\/journal.pone.0170108","journal-title":"PLoS One"},{"issue":"8","key":"6656_CR13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/acr.22271","volume":"66","author":"A Lertratanakul","year":"2014","unstructured":"Lertratanakul A, Wu P, Dyer AR et al (2014) Risk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 66(8):1177\u20131185. https:\/\/doi.org\/10.1002\/acr.22271","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"6656_CR14","doi-asserted-by":"publisher","first-page":"R54","DOI":"10.1186\/ar4489","volume":"16","author":"M Frerix","year":"2014","unstructured":"Frerix M, Stegbauer J, Kreuter A, Weiner SM (2014) Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events. Arthritis Res Ther 16(1):R54. https:\/\/doi.org\/10.1186\/ar4489","journal-title":"Arthritis Res Ther"},{"key":"6656_CR15","doi-asserted-by":"publisher","first-page":"152037","DOI":"10.1016\/j.semarthrit.2022.152037","volume":"55","author":"J Rueda-Gotor","year":"2022","unstructured":"Rueda-Gotor J, Ferraz-Amaro I, Genre F et al (2022) Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients. Semin Arthritis Rheum 55:152037. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152037","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"6656_CR16","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/jcm11030662","volume":"11","author":"M Rojas-Gim\u00e9nez","year":"2022","unstructured":"Rojas-Gim\u00e9nez M, L\u00f3pez-Medina C, Ladehesa-Pineda ML et al (2022) Subclinical atherosclerosis measure by carotid ultrasound and inflammatory activity in patients with rheumatoid arthritis and spondylarthritis. J Clin Med 11(3):662. https:\/\/doi.org\/10.3390\/jcm11030662","journal-title":"J Clin Med"},{"issue":"3","key":"6656_CR17","doi-asserted-by":"publisher","first-page":"101439","DOI":"10.1016\/j.berh.2019.101439","volume":"33","author":"J Lampa","year":"2019","unstructured":"Lampa J (2019) Pain without inflammation in rheumatic diseases. Best Pract Res Clin Rheumatol 33(3):101439. https:\/\/doi.org\/10.1016\/j.berh.2019.101439","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6 Suppl 69","key":"6656_CR18","first-page":"S79","volume":"29","author":"MG Haviland","year":"2011","unstructured":"Haviland MG, Banta JE, Przekop P (2011) Fibromyalgia: prevalence, course, and co-morbidities in hospitalized patients in the United States, 1999-2007. Clin Exp Rheumatol 29(6 Suppl 69):S79\u2013S87","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"6656_CR19","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s10067-019-04429-0","volume":"38","author":"EE Gunturk","year":"2019","unstructured":"Gunturk EE, Ekiz T, Akkaya H (2019) Evaluation of carotid-femoral pulse wave velocity, aortic stiffness index, and aortic distensibility in patients with fibromyalgia. Clin Rheumatol 38(6):1731\u20131735. https:\/\/doi.org\/10.1007\/s10067-019-04429-0","journal-title":"Clin Rheumatol"},{"issue":"12","key":"6656_CR20","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3390\/biomedicines9121786","volume":"9","author":"Y Kim","year":"2021","unstructured":"Kim Y, Kim GT, Kang J (2021) Carotid arterial stiffness and cardiometabolic profiles in women with fibromyalgia. Biomedicines 9(12):1786. https:\/\/doi.org\/10.3390\/biomedicines9121786","journal-title":"Biomedicines"},{"issue":"3","key":"6656_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10067-022-06385-8","volume":"42","author":"BF Kocyigit","year":"2023","unstructured":"Kocyigit BF, Akyol A (2023) Coexistence of fibromyalgia syndrome and inflammatory rheumatic diseases, and autonomic cardiovascular system involvement in fibromyalgia syndrome. Clin Rheumatol 42(3):645\u2013652. https:\/\/doi.org\/10.1007\/s10067-022-06385-8","journal-title":"Clin Rheumatol"},{"issue":"5","key":"6656_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1136\/annrheumdis-2011-201178","volume":"72","author":"TA Hoeven","year":"2013","unstructured":"Hoeven TA, Kavousi M, Clockaerts S et al (2013) Association of atherosclerosis with presence and progression of osteoarthritis: the Rotterdam study. Ann Rheum Dis 72(5):646\u2013651. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201178","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"6656_CR23","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1007\/s10067-016-3391-x","volume":"35","author":"WS Chung","year":"2016","unstructured":"Chung WS, Lin HH, Ho FM, Lai CL, Chao CL (2016) Risks of acute coronary syndrome in patients with osteoarthritis: a nationwide population-based cohort study. Clin Rheumatol 35(11):2807\u20132813. https:\/\/doi.org\/10.1007\/s10067-016-3391-x","journal-title":"Clin Rheumatol"},{"issue":"2","key":"6656_CR24","doi-asserted-by":"publisher","first-page":"e0281067","DOI":"10.1371\/journal.pone.0281067","volume":"18","author":"SJ Ha","year":"2023","unstructured":"Ha SJ, Park SJ, Lee B, Moon H, Kim BY (2023) Clinical outcomes of patients with rheumatoid arthritis who underwent percutaneous coronary intervention: a Korean nationwide cohort study. PLoS One 18(2):e0281067. https:\/\/doi.org\/10.1371\/journal.pone.0281067","journal-title":"PLoS One"},{"issue":"6","key":"6656_CR25","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/art.39098","volume":"67","author":"DH Solomon","year":"2015","unstructured":"Solomon DH, Reed GW, Kremer JM (2015) Disease activity in rheumatoid arthritis and the risk of cardiovascular events. Arthritis Rheumatol 67(6):1449\u20131455. https:\/\/doi.org\/10.1002\/art.39098","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"6656_CR26","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/acr.23567","volume":"70","author":"K Lauper","year":"2018","unstructured":"Lauper K, Courvoisier DS, Chevallier P, Finckh A, Gabay C (2018) Incidence and prevalence of major adverse cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. Arthritis Care Res (Hoboken) 70(12):1756\u20131763. https:\/\/doi.org\/10.1002\/acr.23567","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"6656_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ijcard.2014.04.086","volume":"174","author":"CH Chou","year":"2014","unstructured":"Chou CH, Lin CL, Chang SN, Lin MC, Kao CH, Huang YJ (2014) A nationwide population-based retrospective cohort study: increased risk of acute myocardial infarction in systemic lupus erythematous patients. Int J Cardiol 174(3):751\u2013753. https:\/\/doi.org\/10.1016\/j.ijcard.2014.04.086","journal-title":"Int J Cardiol"},{"issue":"11","key":"6656_CR28","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1007\/s10067-022-06302-z","volume":"41","author":"AN Shams-Eldin","year":"2022","unstructured":"Shams-Eldin AN, Yafasova A, Faurschou M et al (2022) Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study. Clin Rheumatol 41(11):3525\u20133536. https:\/\/doi.org\/10.1007\/s10067-022-06302-z","journal-title":"Clin Rheumatol"},{"issue":"10","key":"6656_CR29","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809\u20131815. https:\/\/doi.org\/10.1136\/ard.2009.114264","journal-title":"Ann Rheum Dis"},{"issue":"10354","key":"6656_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","volume":"400","author":"N Conrad","year":"2022","unstructured":"Conrad N, Verbeke G, Molenberghs G et al (2022) Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet 400(10354):733\u2013743. https:\/\/doi.org\/10.1016\/S0140-6736(22)01349-6","journal-title":"Lancet"},{"issue":"7","key":"6656_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","volume":"7","author":"DP Symmons","year":"2011","unstructured":"Symmons DP, Gabriel SE (2011) Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 7(7):399\u2013408. https:\/\/doi.org\/10.1038\/nrrheum.2011.75","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"6656_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis 76(1):17\u201328. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209775","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6656_CR33","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s10067-017-3551-7","volume":"36","author":"DA Galarza-Delgado","year":"2017","unstructured":"Galarza-Delgado DA, Azpiri-Lopez JR, Colunga-Pedraza IJ et al (2017) Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015\/2016 recommendations for cardiovascular risk management. Clin Rheumatol 36(6):1387\u20131393. https:\/\/doi.org\/10.1007\/s10067-017-3551-7","journal-title":"Clin Rheumatol"},{"issue":"7","key":"6656_CR34","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/rheumatology\/kex038","volume":"56","author":"CS Crowson","year":"2017","unstructured":"Crowson CS, Gabriel SE, Semb AG et al (2017) Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries. Rheumatology (Oxford) 56(7):1102\u20131110. https:\/\/doi.org\/10.1093\/rheumatology\/kex038","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"6656_CR35","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41584-020-0428-y","volume":"16","author":"AG Semb","year":"2020","unstructured":"Semb AG, Ikdahl E, Wibetoe G, Crowson C, Rollefstad S (2020) Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis. Nat Rev Rheumatol 16(7):361\u2013379. https:\/\/doi.org\/10.1038\/s41584-020-0428-y","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"6656_CR36","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S2665-9913(20)30221-6","volume":"3","author":"R Hansildaar","year":"2021","unstructured":"Hansildaar R, Vedder D, Baniaamam M, Tausche AK, Gerritsen M, Nurmohamed MT (2021) Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout. Lancet Rheumatol 3(1):e58\u2013e70. https:\/\/doi.org\/10.1016\/S2665-9913(20)30221-6","journal-title":"Lancet Rheumatol"},{"issue":"12","key":"6656_CR37","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1007\/s00380-022-02114-y","volume":"37","author":"GV Papamichail","year":"2022","unstructured":"Papamichail GV, Markatseli TE, Georgiadis AN et al (2022) The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study. Heart Vessels 37(12):2128\u20132136. https:\/\/doi.org\/10.1007\/s00380-022-02114-y","journal-title":"Heart Vessels"},{"issue":"1","key":"6656_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/1744666X.2019.1699058","volume":"16","author":"S Casta\u00f1eda","year":"2020","unstructured":"Casta\u00f1eda S, Vicente-Rabaneda EF, Garc\u00eda-Casta\u00f1eda N, Prieto-Pe\u00f1a D, Dessein PH, Gonz\u00e1lez-Gay MA (2020) Unmet needs in the management of cardiovascular risk in inflammatory joint diseases. Expert Rev Clin Immunol 16(1):23\u201336. https:\/\/doi.org\/10.1080\/1744666X.2019.1699058","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"6656_CR39","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/annrheumdis-2015-208916","volume":"75","author":"C Strehl","year":"2016","unstructured":"Strehl C, Bijlsma JW, de Wit M et al (2016) Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. Ann Rheum Dis 75(6):952\u2013957. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208916","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"6656_CR40","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/rheumatology\/ker410","volume":"51","author":"G Ruiz-Irastorza","year":"2012","unstructured":"Ruiz-Irastorza G, Danza A, Khamashta M (2012) Glucocorticoid use and abuse in SLE. Rheumatology (Oxford) 51(7):1145\u20131153. https:\/\/doi.org\/10.1093\/rheumatology\/ker410","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"6656_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16(3):155\u2013166. https:\/\/doi.org\/10.1038\/s41584-020-0372-x","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"6656_CR42","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00296-020-04694-2","volume":"40","author":"DP Misra","year":"2020","unstructured":"Misra DP, Gasparyan AY, Zimba O (2020) Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates. Rheumatol Int 40(11):1741\u20131751. https:\/\/doi.org\/10.1007\/s00296-020-04694-2","journal-title":"Rheumatol Int"},{"issue":"2","key":"6656_CR43","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.mcna.2020.09.010","volume":"105","author":"LD Ferguson","year":"2021","unstructured":"Ferguson LD, Sattar N, McInnes IB (2021) Managing cardiovascular risk in patients with rheumatic disease. Med Clin North Am 105(2):247\u2013262. https:\/\/doi.org\/10.1016\/j.mcna.2020.09.010","journal-title":"Med Clin North Am"},{"key":"6656_CR44","doi-asserted-by":"publisher","unstructured":"Bodur H (2022) Cardiovascular comorbidities in spondyloarthritis. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-022-06473-9 Online ahead of print","DOI":"10.1007\/s10067-022-06473-9"},{"issue":"2","key":"6656_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00296-017-3895-y","volume":"38","author":"P Patel","year":"2018","unstructured":"Patel P, Rosen CF, Chandran V, Ye YJ, Gladman DD (2018) Addressing comorbidities in psoriatic disease. Rheumatol Int 38(2):219\u2013227. https:\/\/doi.org\/10.1007\/s00296-017-3895-y","journal-title":"Rheumatol Int"},{"issue":"5","key":"6656_CR46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/acr2.11136","volume":"2","author":"S Banerjee","year":"2020","unstructured":"Banerjee S, George MD, Singh S et al (2020) (2020) Patient perception of cardiovascular risk in rheumatoid arthritis. ACR Open Rheumatol 2(5):255\u2013260. https:\/\/doi.org\/10.1002\/acr2.11136","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"6656_CR47","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/msc.1196","volume":"16","author":"K Ladak","year":"2018","unstructured":"Ladak K, Hashim J, Clifford-Rashotte M, Tandon V, Matsos M, Patel A (2018) Cardiovascular risk management in rheumatoid arthritis: a large gap to close. Musculoskelet Care 16(1):152\u2013157. https:\/\/doi.org\/10.1002\/msc.1196","journal-title":"Musculoskelet Care"},{"issue":"3","key":"6656_CR48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s10067-019-04901-x","volume":"39","author":"S Pak","year":"2020","unstructured":"Pak S (2020) Primary care providers\u2019 awareness, knowledge, and practice with regard to cardiovascular risk in patients with rheumatoid arthritis: PCPs\u2019 awareness, knowledge, and practice with regard to CV risks in patients with RA. Clin Rheumatol 39(3):755\u2013760. https:\/\/doi.org\/10.1007\/s10067-019-04901-x","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06656-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06656-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06656-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T14:06:02Z","timestamp":1699884362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06656-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,3]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6656"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06656-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,3]]},"assertion":[{"value":"15 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}